# Impact of Systematic Imaging for Follow up of Patients With Ovarian, Fallopian Tube or Primary Peritoneum Cancer

> **NCT04826029** · NA · WITHDRAWN · sponsor: **Assistance Publique - Hôpitaux de Paris**

## Conditions studied

- Advanced Stage Serous Epithelial Cancer of the Ovary
- Advanced Stage Cancer of Tubes
- Advanced Stage Cancer of Peritoneum

## Interventions

- **OTHER:** Standard strategy
- **OTHER:** Follow-up strategy

## Key facts

- **NCT ID:** NCT04826029
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-06-22
- **Primary completion:** 2021-06-22
- **Final completion:** 2021-06-22
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No longer feasible because of new recommendations (RPC St Paul de Vence) which advocate the performance of systematic imaging in addition to CA 125 in patients treated in first line maintenance in order not to ignore a relapse (2021).
- **Last updated:** 2021-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04826029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04826029, "Impact of Systematic Imaging for Follow up of Patients With Ovarian, Fallopian Tube or Primary Peritoneum Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04826029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*